XML 30 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Balance Sheets (Unaudited) (USD $)
In Thousands, unless otherwise specified
Mar. 31, 2012
Dec. 31, 2011
ASSETS:    
Cash and cash equivalents $ 533,812 $ 574,231
Short-term investments 273,238 238,884
Accounts Receivable, Net 387,619 398,674
Inventories:    
Raw materials 102,444 99,326
Work in process 125,813 120,191
Finished goods 235,112 213,993
Total inventories 463,369 433,510
Prepaid expenses, taxes and other current assets 159,410 152,856
Total current assets 1,817,448 1,798,155
Property, plant and equipment, at cost 925,489 881,912
Less: accumulated depreciation and amortization (556,290) (532,411)
Property, plant and equipment, net 369,199 349,501
Goodwill, net 480,060 468,933
Purchased intangibles, net 258,312 259,497
Other assets 262,855 220,717
Total assets 3,187,874 3,096,803
LIABILITIES AND STOCKHOLDERS' EQUITY:    
Accounts payable 109,571 129,124
Accrued payroll and employee benefits 119,749 112,564
Notes payable and current maturities of long-term debt 809 814
Income and other taxes payable 50,032 52,285
Accrued royalties 22,933 25,219
Other current liabilities 140,986 139,109
Total current liabilities 444,080 459,115
Long-term debt, net of current maturities 731,899 731,698
Other long-term liabilities 171,849 161,608
Total liabilities 1,347,828 1,352,421
Bio-Rad stockholders' equity:    
Additional paid-in capital 192,341 185,334
Retained earnings 1,390,915 1,359,910
Accumulated other comprehensive income 256,390 198,690
Total Bio-Rad stockholders' equity 1,839,649 1,743,937
Noncontrolling interests 397 445
Total stockholders' equity 1,840,046 1,744,382
Total liabilities and stockholders' equity 3,187,874 3,096,803
Common Class A [Member]
    
Bio-Rad stockholders' equity:    
Common stock 2 2
Common Class B [Member]
    
Bio-Rad stockholders' equity:    
Common stock $ 1 $ 1